Abrdn World Healthcare Fund (NYSE:THW) Sees Large Decrease in Short Interest

Abrdn World Healthcare Fund (NYSE:THW) was the recipient of a large decrease in short interest during the month of July. As of July 31st, there was short interest totaling 50,789 shares, a decrease of 71.5% from the July 15th total of 177,929 shares. Based on an average daily trading volume, of 194,716 shares, the days-to-cover ratio is currently 0.3 days.

Abrdn World Healthcare Fund Stock Performance

THW stock opened at $13.97 on Thursday. The firm’s 50-day moving average is $13.13 and its two-hundred day moving average is $12.69. Abrdn World Healthcare Fund has a 52 week low of $10.84 and a 52 week high of $14.00.

Abrdn World Healthcare Fund Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Monday, August 31st. Shareholders of record on Monday, August 24th will be given a $0.1167 dividend. This represents a c) dividend on an annualized basis and a yield of 10.0%. The ex-dividend date is Monday, August 24th.

Hedge Funds Weigh In On Abrdn World Healthcare Fund

Several hedge funds have recently modified their holdings of THW. Allied Private Wealth LLC acquired a new stake in shares of Abrdn World Healthcare Fund in the second quarter valued at $27,000. Advisory Services Network LLC acquired a new position in Abrdn World Healthcare Fund during the third quarter worth about $43,000. B. Riley Wealth Advisors Inc. bought a new stake in Abrdn World Healthcare Fund in the second quarter worth about $113,000. Mercer Global Advisors Inc. ADV bought a new stake in Abrdn World Healthcare Fund in the fourth quarter worth about $157,000. Finally, HighTower Advisors LLC acquired a new stake in Abrdn World Healthcare Fund in the 4th quarter valued at about $168,000.

About Abrdn World Healthcare Fund

Abrdn World Healthcare Fund (NYSE: THW) is a closed-end investment company that provides investors with diversified exposure to the global healthcare sector. Listed on the New York Stock Exchange, the fund seeks to deliver long-term capital appreciation by investing primarily in equity securities of companies engaged in pharmaceuticals, biotechnology, medical devices, healthcare services and related industries. Managed by the global healthcare equity team at Abrdn plc, the fund leverages the firm’s deep sector expertise and research capabilities to identify innovative businesses and established market leaders in both developed and emerging markets.

The fund’s portfolio spans a broad range of healthcare subsectors, including drug developers, medical equipment manufacturers, health insurers and providers of diagnostics and digital health solutions.